- 17 December
-
Medsintez Plant, one of the leading pharmaceutical companies in the Urals, partnered with the 15th Anniversary Festival of Expectant Mothers in the Sverdlovsk Region. The event, aimed at strengthening family values and supporting motherhood, was held in Ekaterinburg with the support of the regional government and as part of the national Family Project.
- 27 November
-
The entry of the Russian antiviral drug TRIAZAVIRIN® into the South African pharmaceutical market opens new opportunities not only for international healthcare cooperation but also for enhancing the health of patients in both countries.
- 05 November
-
Medsintez Plant participated in a key industry event, Product Innovation Fair in Medicine and Healthcare, which took place in Moscow on October 29–30. Viktor Fisenko, First Deputy Minister of Healthcare of Russia, attended the exhibition of domestic innovations in the field of drugs and medical products.
- 25 October
-
The 3d Scientific and Practical Conference The Ural Peaks. Respiratory Infections 2025 was held in Ekaterinburg on October 15–16 as part of the 4th International Forum Days of Virology 2025. The event organized by the Ministry of Health of the Sverdlovsk Region, the Smorodintsev Research Institute of Influenza, and the Ural State Medical University brought together over 1,100 participants in person and online from 36 cities across Russia.
- Home
- Cluster members
- Joint Stock Company «Uralbiopharm»
Joint Stock Company «Uralbiopharm»
Joint Stock Company «Uralbiopharm» stands as the preeminent manufacturer of contemporary pharmaceutical preparations and biologically active supplements in the Ural region.
Established in 1930, the enterprise formally commemorated its 95th anniversary on 1 October 2025.
Contemporary Profile of Uralbiopharm:
Designated as a systemically significant enterprise of the Russian Federation, actively participating in the national project «Labor Productivity»
Land area: 22,500 m²
Seven production facilities encompassing 3,280 m² of manufacturing space
Production of medicinal products for human medical and veterinary applications, alongside biologically active supplements
Participant in the import substitution initiative, undertaken in partnership with the Government of Sverdlovsk Oblast
An enterprise committed to perpetual advancement; since 2021, under the modernization and development program, acquisition of 13 units of packaging, labeling, and aggregation equipment has been completed
Exportation of pharmaceuticals to: the Republic of Uzbekistan, the Republic of Kazakhstan, the Kyrgyz Republic, Turkmenistan, the Republic of Tajikistan, the Republic of Belarus, Georgia, the Democratic People's Republic of Korea, and Mongolia
Contract manufacturing facility serving premier Russian pharmaceutical manufacturers
The enterprise has endorsed a strategic development plan for 2025–2032, encompassing:
The development and production of more than 70 novel pharmaceutical preparations and biologically active supplements
Construction of a state-of-the-art, technologically advanced production complex, tripling overall manufacturing capacity
Engagement in principal strategic federal initiatives pursuant to the «Pharma 2030» program
Establishment of scientific research and development operations in collaboration with Russia's leading specialized higher education institutions
Generation of over 150 new employment positions
Distinguishing Characteristics of JSC «Uralbiopharm» Products:
A substantial proportion of its preparations is incorporated into the List of Vital and Essential Drugs promulgated by the Russian Ministry of Health, affirming their paramount social significance
Rigorous quality control is maintained across all stages of production
The portfolio comprises both established medicinal products and innovative biologically active supplements and preparations designed to enhance immune function, alleviate stress, and sustain health amid viral infections
JSC «Uralbiopharm» furnishes an extensive array of high-demand pharmaceuticals that enable individuals to address acute and chronic pathologies, fortify immunological defenses, and elevate their overall quality of life.
Adress: 60, Kuibysheva st., Ekaterinburg, Sverdlovsk region, 620026
Теl. +7 343 254-01-93
Email: ubf@ubf.ru
Website: ubf.ru
Social media: https://vk.com/uralbiofarm
